Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Targeted Therapies for Targeted Populations: Anti-EGFR Treatment for EGFR-Amplified Gastroesophageal Adenocarcinoma.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Targeted Therapies for Targeted Populations: Anti-EGFR Treatment for EGFR-Amplified Gastroesophageal Adenocarcinoma.
Targeted Therapies for Targeted Populations: Anti-EGFR Treatment for EGFR-Amplified Gastroesophageal Adenocarcinoma. Cancer Discov. 2018 06; 8(6):696-713.
View in:
PubMed
subject areas
Adolescent
Adult
Aged
Aged, 80 and over
Antibodies, Monoclonal, Humanized
Antineoplastic Combined Chemotherapy Protocols
Camptothecin
Cell Line, Tumor
Cetuximab
Colorectal Neoplasms
Disease-Free Survival
ErbB Receptors
Female
Fluorouracil
Gene Amplification
High-Throughput Nucleotide Sequencing
Humans
Intention to Treat Analysis
Leucovorin
Male
Middle Aged
Molecular Targeted Therapy
Organoplatinum Compounds
Prospective Studies
Response Evaluation Criteria in Solid Tumors
Retrospective Studies
Sequence Analysis, DNA
Treatment Outcome
Young Adult
authors with profiles
Namrata Setia
Lindsay Alpert
Shu-Yuan Xiao